Does “Dual Trigger” Increase Oocyte Maturation Rate?

Avi Ben-Haroush 1,2 Onit Sapir 1,2 Eran Altman 1,2 Moria Kirshner 1,2 Roni Bargil 1,2 Tamar Margalit 1,2 Yoel Shufaro 1,2 Galia Oron 1,2
1IVF and Infertility Unit, Rabin Medical Center
2Sackler Faculty of Medicine, Tel Aviv University

Introduction: The LH activity of hCG replaces the preovulatory LH peak and is more prolonged, whereas GnRH-a triggering reproduces the more physiological dual LH and FSH peak.The effect of the simultaneous co-administration of GnRH-a and hCG 36-38 hours prior to oocyte pick-up (dual trigger) on oocyte maturity rates was evaluated in a few studies reaching conflicting results.

Aim: Does the co-administration of GnRH agonist (GnRH-a) and hCG for final oocyte maturation triggering increase the oocyte maturation rate in comparison to the standard hCG trigger?

Materials and methods: Retrospective analysis of GnRH antagonist ICSI cycles performed in patients who had one standard hCG trigger cycle and one dual trigger cycle and fresh ETs between 1/1/2013 and 31/12/2017. The study included 136 patients. The outcome of the dual trigger cycles was compared to results of the hCG trigger cycles in the same patients.

Results: Overall, oocyte maturation rate was identical in both groups (81%). Among 34 patients who had a maturation rate of <70% following hCG triggering, there was a significantly higher oocyte maturation rate following dual trigger (54% versus 74%, p<0.001). Among 16 patients with a lower than 50% oocyte maturation rate following hCG trigger, there was a significantly higher maturation rate following dual trigger (44% versus 73%, p=0.006).

Conclusions: The co-administration of GnRH agonist and hCG for final oocyte maturation substantially increases the oocyte maturation rate in patients who had a low oocyte maturation rate in a previous hCG triggered cycle, but not in an unselected population of patients.

Avi Ben-Haroush
Avi Ben-Haroush








Powered by Eventact EMS